• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number FG540000
Device Problems Signal Artifact/Noise (1036); Computer Software Problem (1112); Patient Device Interaction Problem (4001)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/12/2021
Event Type  Injury  
Manufacturer Narrative
Device evaluation details: field service engineer performed troubleshooting onsite and was unable to replicate the issue with account 12 lead and field service engineer electrocardiogram testing cable.Field service engineer tested the system per the acceptance testing procedure, and all requirements passed.The system is functioning as expected and is ready for use.Non-manufacturing related potential cause has been identified, therefore no manufacturing record evaluation is required.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that during an atrial fibrillation (afib) ablation procedure, the carto(r) 3 system had error 1201 ecg (electrocardiogram) lead limb disconnection as well as a 19 failure in the patient interface unit (piu) ecg1 cart bit intermittently.The disposable limb lead patches were replaced, the electrocardiogram (ecg) cable was reseated and the patient interface unit was rebooted; however, the issue did not resolve.The patient interface unit and workstation were rebooted but the issue remained.The 12 lead body surface cable was replaced, and the issue remained.Reminder of the procedure was aborted.No ablation therapy could be performed.The physician was able to monitor patient's heart rhythm through the anestesia ecg monitor at all time.The patient was under general anesthesia for 1 hour and 50 minutes.No transseptal puncture was done prior to the case cancellation.The physician did not consider that cancelling the procedure represented an increased risk to the patient.There was no exacerbation of patient's disease.No additional intervention nor prolonged hospitalization were required.The ecg lead limb disconnection is not mdr-reportable.The piu 19 issue is not mdr-reportable.However, the absence of treatment is mdr-reportable.
 
Manufacturer Narrative
It was reported that during an atrial fibrillation (afib) ablation procedure, the carto® 3 system wherein a procedure cancellation occurred as the carto® 3 system had error 1201 ecg (electrocardiogram) lead limb disconnection as well as a 19 failure in the patient interface unit (piu) ecg1 cart bit intermittently.The physician did not consider that cancelling the procedure represented an increased risk to the patient.There was no exacerbation of patient¿s disease.No additional intervention nor prolonged hospitalization were required.Device evaluation details: additional investigation was performed as the issue was further analyzed by the device manufacturer.The issue was investigated by the device manufacturer.Based on the study data analysis, it was confirmed that the error 19 occurred twice, each time about 10-15 second until the error disappeared.After that the error didn¿t appear again.It was also confirmed that the error 1201 appeared much later than the error 19 and regardless of error 19.The root cause for error 1201 cannot be determined.Also, the field service engineer (fse) didn't find any problem during the system check on site.In addition, the history of customer complaints associated with this specific system was reviewed and it was found that the issue was not reported anymore.System is operational.The history of customer complaints reported during the last year associated with carto 3 system # 13184 was reviewed.No similar complaints were found.A manufacturing record evaluation was performed for the carto 3 system # 13184, and no internal action related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Manufacturer Narrative
Manufacturer's ref # (b)(4) on (b)(6)2021, during an internal review of the reported event, it was determined that the reported event of "absence of treatment" is to be considered a non-serious patient event and not mdr reportable since the physician did not consider that cancelling the procedure (absence of treatment) represented an increased risk to the patient.There was no exacerbation of patient¿s disease.No additional intervention nor prolonged hospitalization were required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key11305448
MDR Text Key231210721
Report Number2029046-2021-00148
Device Sequence Number1
Product Code DQK
UDI-Device Identifier10846835000870
UDI-Public10846835000870
Combination Product (y/n)N
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 01/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberFG540000
Device Catalogue NumberFG540000
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/13/2021
Initial Date FDA Received02/09/2021
Supplement Dates Manufacturer Received03/14/2021
05/27/2021
Supplement Dates FDA Received04/09/2021
06/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNSPECIFIED ECG CABLE; UNSPECIFIED ECG CABLE
Patient Outcome(s) Other;
-
-